Latest Breaking News On - Metrax gmb - Page 4 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 21.6 Bn in 2020 and is expected to reach USD 27.31 Bn by 2025, growing at a CAGR of 4.8%. Market Dynamics The increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. The implantable device technology uses complementary metal-oxide-semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use. This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. On the other hand, the high cost of these devices with limited insurance coverage is limiting the growth of the market.

United statesUnited kingdomSouth africaUnited arab emiratesSaudi arabiaSouth koreaProgetti srlMetrax gmbMindray bioLaura woodShree pacetronixKoninklijke philipsBoston scientific corporationCardionet incRom holdings incAsahi kasei corporation